RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Quality & Compliance: An NDA for Water

Quality & Compliance: An NDA for Water

Posted 01 February 2008 | By

This is a case study about the requirement of a New Drug Application (NDA) for water as the active pharmaceutical ingredient (API) of an eyewash product. It is an ongoing case, representing an unforeseen glitch in the regulations. Most of the information is public but I will not name the company.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.